Form 8-K - Current report:
SEC Accession No. 0001193125-14-306673
Filing Date
2014-08-12
Accepted
2014-08-12 16:18:07
Documents
3
Period of Report
2014-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d773790d8k.htm 8-K 16481
2 EX-99.1 d773790dex991.htm EX-99.1 135382
3 GRAPHIC g773790g40u04.jpg GRAPHIC 5040
  Complete submission text file 0001193125-14-306673.txt   160022
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 141034167
SIC: 2835 In Vitro & In Vivo Diagnostic Substances